Aldeyra Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2013 to Q3 2024.
  • Aldeyra Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.02M, a 24.9% decline year-over-year.
  • Aldeyra Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $4.84M, a 2.98% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $5.25M, a 701% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $655K.
  • Aldeyra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.56M, a 3.43% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.84M $1.02M -$339K -24.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $5.18M $1.16M -$195K -14.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $5.38M $1.31M +$124K +10.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $5.25M $1.34M +$550K +69.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $4.7M $1.36M +$1.13M +489% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $3.57M $1.36M +$1.42M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $2.15M $1.19M +$1.49M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $655K $795K +$1.14M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$490K $231K +$585K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$1.07M -$66K +$328K +83.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$1.4M -$305K +$154K +33.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$1.56M -$350K +$134K +27.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$1.69M -$354K +$130K +26.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$1.82M -$394K +$20.5K +4.95% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$1.84M -$459K -$229K -99.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$1.61M -$484K -$219K -82.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$1.39M -$484K -$785K -261% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$608K -$414K -$819K -202% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $211K -$230K -$727K -146% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $938K -$265K -$727K -157% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $1.66M $301K +$167K +124% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.5M $404K +$289K +250% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.21M $497K +$403K +427% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $806K $462K +$370K +402% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $436K $134K +$105K +361% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $331K $116K +$93.7K +427% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $237K $94.3K +$89.6K +1874% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $148K $92K +$90.5K +5754% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 $57.3K $29.1K +$27.9K +2455% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $29.4K $21.9K +$27.8K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.62K $4.78K +$5.1K Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 -$3.47K $1.57K +$18.4K Oct 1, 2016 Dec 31, 2016 10-K 2017-03-30
Q3 2016 -$21.9K $1.14K +$29.2K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$51.1K -$5.87K +$22.3K +79.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$73.5K -$316* +$27.7K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$101K -$16.9K +$16.8K +49.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$118K -$28.1K +$13K +31.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$131K -$28.2K -$540K -106% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $409K -$28K -$1.67M -102% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $2.08M -$33.6K -$10.6M -100% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $12.6M -$41.1K -$10.5M -100% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $23.2M $511K +$1.09M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $22.1M $1.65M +$5.33M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $16.7M $10.5M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 $10.5M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$583K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$3.68M Jan 1, 2013 Mar 31, 2013 10-Q 2014-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.